Effects of nitric oxide synthase inhibition on the cardiovascular response to low output shock

Critical Care Medicine

Volumn 24, Issue 3, 1996, Pages 482-487

  Lorente, Jose A ^b   Landín, Luis ^a   Cañas, Paloma ^b   Delgado, Miguel A ^b   Albaya, Antonio ^b   Renes, Emilio ^b   Jorge, Pablo ^b   Liste, David ^b  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b NONE

Author keywords

critical illness; dexamethasone; hemodynamics; hypotension; nitric oxide; oxygen consumption; oxygen transport; sheep; shock; vasodilation

Indexed keywords

DEXAMETHASONE; LACTIC ACID; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PYRUVIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL REACTIVITY; BLOOD VESSEL TONE; CARDIOVASCULAR EFFECT; CONTROLLED STUDY; CRITICAL ILLNESS; FORWARD HEART FAILURE; HEART INDEX; HYPOTENSION; NONHUMAN; OXYGEN TRANSPORT; PRIORITY JOURNAL; SHEEP; SHOCK;

ANALYSIS OF VARIANCE; ANIMALS; ARGININE; CARDIAC OUTPUT, LOW; CARDIOVASCULAR SYSTEM; DEXAMETHASONE; DISEASE MODELS, ANIMAL; NITRIC OXIDE SYNTHASE; NITROARGININE; PROSPECTIVE STUDIES; SHEEP; SHOCK, CARDIOGENIC;

EID: 0029913140     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199603000-00019     Document Type: Article

References (33)

1. Aisaka K, Gross SS, Griffith OW, et al: NG-Methylarginine, an inhibitor of endothelium-derived nitric oxide synthesis is a potent pressor agent in the guinea pig: Does nitric oxide regulate blood pressure in vivo? Biochem Biophys Res Commun 1989; 160:881-886
2. Rees DD, Palmer RMJ, Moncada S: Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci U S A 1989; 86:3375-3378
3. Vallance P, Collier J, Moncada S: Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 1989; 8670:997-1000
4. Gonzalez C, Fernandez A, Martin C, et al: Nitric oxide from endothelium and smooth muscle modulates responses to sympathetic nerve stimulation: Implications for endotoxin shock. Biochem Biophys Res Commun 1992; 186:150-156
5. Navarro J, Sanchez A, Diz J, et al: Hormonal, renal and metabolic alterations during hypertension induced by chronic inhibition of NO in rats. Am J Physiol 1994; 267:R1516-R1521
6. Panza JA, Quyyumi A, Brush JE Jr, et al: Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990; 323:22-27
7. Guerra R Jr, Brotherton AFA, Goodwin PJ, et al: Mechanisms of abnormal endothelium-dependent vascular relaxation in atherosclerosis: Implications for altered autocrine and paracrine functions of EDRF. Blood Vessels 1989; 26: 300-314
8. Egashira K, Inou T, Hirooka Y, et al: Evidence of impaired endothelium-dependent coronary vasodilation in patients with angina pectoris and normal coronary angiograms. N Engl J Med 1993; 328:1659-1664
9. Archer SL, Tolins JP, Raij L, et al: Hypoxic pulmonary vasoconstriction is enhanced by inhibition of the synthesis of an endothelium derived relaxing factor. Bichem Biophys Res Commun 1989; 164:1198-1205
10. G-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: Implications for the involvement of nitric oxide. Proc Natl Acad Sci U S A 1990; 87:3629-3632
11. Kilbourn RG, Jubran A, Gross SS, et al: Reversal of endotoxin-mediated shock by NG-methyl-L-arginine, an inhibitor of nitric oxide synthesis. Biochem Biophys Res Commun 1990; 172:1132-1138
12. Lorente JA, Landín L, Renes E, et al: Role of nitric oxide in the hemodynamic changes of sepsis. Crit Care Med 1993; 21:759-767
13. Petros A, Lamb G, Leone A, et al: Effects of a nitric oxide inhibitor in humans with septic shock. Cardiovasc Res 1994; 28:34-39
14. Lorente JA, Landín L, de Pablo R, et al: The L-arginine pathway in the sepsis syndrome. Crit Care Med 1993; 21: 1287-1295
15. Ontkean M, Gay R, Greenberg B: Diminished endothelium-derived relaxing factor activity in an experimental model of chronic heart failure. Circ Res 1991; 69:1088-1096
16. Mayhan WG, Rubinsten I: Acetylcholine induces vasoconstriction in the microcirculation of cardiomyopathic hamsters: Reversal by L-arginine. Biochem Biophys Res Commun 1992; 184:1372-1377
17. Rees DD, Palmer RMJ, Schulz R, et al: Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol 1990; 101: 746-752
18. Moncada S: Endogenous nitric oxide: Physiology, pathology and clinical relevance. Eur J Clin Invest 1991; 21: 361-374
19. Marbach EP, Weil MH: Rapid enzymatic measurement of blood lactate and pyruvate. Clin Chem 1967; 13:314-325
20. Czok R, Lamprecht W: Pyruvate measurements. In: Methoden der enzymatischen analyse. Third Edition. Vol II. Bermeyer HU (Ed). Weinheim, Germany, Verlag Chemie, 1974, p 1491
21. G-methylarginine. Biochem Biophys Res Commun 1990; 170:96-103
22. Rees DD, Cellek S, Palmer RMJ, et al: Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: An insight into endotoxin shock. Biochem Biophys Res Commun 1990; 173:541-547
23. ω-nitro-L-arginine in rats. Br J Pharmacol 1994; 111: 394-396
24. Fink MP: Shock: An overview. In: Intensive Care Medicine. Rippe JM, Irwin RS, Alpert JS, et al (Eds). Boston, Little, Brown and Co, 1991, pp 1417-1435
25. Gold ME, Wood KS, Buga GM, et al: L-arginine causes whereas L-arginino-succinic acid inhibits endothelium-dependent vascular smooth muscle relaxation. Biochem Biophys Res Commun 1989; 161:536-543
26. Beasley D, Schwartz JH, Brenner BM: Interleukin-1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells. J Clin Invest 1991; 87:602-608
27. Knowles RG, Moncada S: Nitric oxide syntheses in mammals. Biochem J 1994; 298:249-258
28. Fleming I, Gray GA, Julou-Schaeffer G, et al: Incubation with endotoxin activates the L-arginine pathway in vascular tissue. Biochem Biophys Res Commun 1990; 171:572-578
29. Kaiser L, Spickard RC, Oliver NB: Heart failure depresses endothelium-dependent responses in canine femoral artery. Am J Physiol 1989; 256:H962-H967
30. Wang J, Seyedi N, Xu X-B, et al: Defective endothelium-mediated control of coronary circulation in conscious dogs after heart failure. Am J Physiol 1994; 266:H670-H680
31. O'Murchu B, Miller VM, Perella MA, et al: Increased production of nitric oxide in coronary arteries during congestive heart failure. J Clin Invest 1994; 93:165-171
32. Elsner D, Muntze A, Kromer E, et al: Systemic vasoconstriction induced by inhibition of nitric oxide synthesis is attenuated in conscious dogs with heart failure. Cardiovasc Res 1991; 25:438-440
33. G-nitro-arginine on endothelium-dependent relaxation of rat aorta. J Pharmacol Exp Ther 1993; 265: 112-119